AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2020
Sep 4, 2020
30786_dirs_2020-09-04_e21a6a6f-2f80-4f2e-a230-10e97e5a6ce5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2020-09-02
Reporting Person: Last Andrew J. (EVP, Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-09-02 | Restricted Stock Units | $0 | A | 3610 | Acquired | Bio-Rad A Common Stock (3610) | Direct | |
| 2020-09-02 | Non-Qualified Stock Option (right to buy) | $524.3 | A | 3610 | Acquired | 2030-09-02 | Bio-Rad A Common Stock (3610) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | Direct |
Footnotes
F1: Includes 23.3089 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2020.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F4: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13